Group 1 - Gilead Sciences showcased its innovative drug, Lenacapavir, which is the world's first long-acting HIV pre-exposure prophylaxis approved for administration twice a year, recently launched in China [1] - The exhibition highlighted 13 innovative drugs launched by Gilead in China, emphasizing the company's commitment to improving drug accessibility and promoting health equity [1] - The event featured various cutting-edge medical technologies, including Siemens Healthineers' photon-counting CT and Medtronic's first-ever rechargeable closed-loop spinal cord stimulation system [1][2] Group 2 - This year's exhibition saw an increase in reception and negotiation spaces for pharmaceutical companies, indicating a growing emphasis on business interactions [2] - A centralized signing hall was established for nearly 200 buyers from central enterprises and health authorities to engage in over 70 signing activities with exhibitors [2] - The overarching theme of the event was to collaboratively "create a healthier world," showcasing new products, technologies, and services [3]
“创造一个更健康的世界”